Vial labeled 'Peptide Therapy Cagrisema 5MG' with a DNA strand in the background

CagriSema (5mg)

$95.00
$95.00 $125.00
Skip to product information
Vial labeled 'Peptide Therapy Cagrisema 5MG' with a DNA strand in the background
  • Vial labeled 'Peptide Therapy Cagrisema 5MG' with a DNA strand in the background
  • Vial labeled 'Peptide Therapy Cagrisema 5MG' with a DNA strand in the background
CagriSema (5mg)

CagriSema (5mg)

$95.00
$95.00 $125.00

CagriSema — 5mg

Product Overview

Research Application: Dual-action co-formulation consisting of an amylin receptor agonist and a GLP-1 receptor agonist investigated for synergistic metabolic signaling.

CagriSema is a premium-grade, highly purified combination compound synthesized for specialized laboratory research.

Key Research Specifications

  • Molecular Composition: Co-formulation of synthesized Cagrilintide and Semaglutide

  • Format: Lyophilized White Powder

  • Recommended Storage: Store at -20°C. Protect from light and moisture.

Primary Research Mechanisms

  • Dual Satiety Pathways: Investigated for concurrent central satiation signaling via brainstem amylin pathways and hypothalamic GLP-1 circuits.

  • Delayed Gastric Emptying: Evaluated for its synergistic decelerating impact on postprandial glucose transitions.

  • Pancreatic Beta-Cell Preservation: Analyzed for protective impacts on insulin secretion kinetics under extreme insulin resistance challenges.

Laboratory & Research Disclaimer

This product is synthesized strictly for laboratory research, analytical, and in vitro experimental use. It is not intended for diagnostic, therapeutic, human, or veterinary administration. All research must be conducted by qualified professionals using appropriate safety protocols.

You may also like